Ondansetron for nausea and vomiting in pregnancy: re-evaluating the teratogenic risk
- PMID: 32284725
- PMCID: PMC7133101
- DOI: 10.1177/1753495X20914967
Ondansetron for nausea and vomiting in pregnancy: re-evaluating the teratogenic risk
References
-
- Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol 2013; 20: e171–e183. - PubMed
-
- Fiaschi L, et al. Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum. Int J Clin Pract 2019; 73: e13261. - PubMed
-
- European Medicines Agency. PRAC recommendations on safety signals. Pharmacovigilance Risk Assessment Committee, https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmac... (2019, accessed 7 March 2020).
Publication types
LinkOut - more resources
Full Text Sources